GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,851.50p
   
  • Change Today:
      24.50p
  • 52 Week High: 2,208.00
  • 52 Week Low: 1,735.50
  • Currency: UK Pounds
  • Shares Issued: 4,045.44m
  • Volume: 1,971,464
  • Market Cap: £74,901m
  • RiskGrade: 129
  • Beta: 0.00

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Sep-26 Q3 8,887.00 1,935.00 54.60p 17.00p

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 24,696.00 3,599.00 90.56p 22.2 n/a -22% 80.00p 4.0%
31-Dec-22 29,324.00 5,628.00 139.70p 10.3 0.2 +54% 44.00p 3.1%
31-Dec-23 30,328.00 6,064.00 155.10p 9.4 0.9 +11% 58.00p 4.0%
31-Dec-24 31,376.00 3,477.00 159.30p 8.5 2.8 +3% 61.00p 4.5%
31-Dec-25 32,667.00 7,401.00 172.00p 10.6 1.3 +8% 66.00p 3.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 33,821.43 9,575.67 179.40p 10.2 2.4 +4% 70.68p 0.0%
31-Dec-27 35,270.25 10,605.19 187.36p 9.8 2.2 +4% 75.58p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 22.18 8.45 12.18 0.94

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

GSK Market Data

Currency UK Pounds
Share Price 1,851.50p
Change Today 24.50p
% Change 1.34 %
52 Week High 2,208.00
52 Week Low 1,735.50
Volume 1,971,464
Shares Issued 4,045.44m
Market Cap £74,901m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
78.37% below the market average78.37% below the market average78.37% below the market average78.37% below the market average78.37% below the market average
7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average
Price Trend
75.05% above the market average75.05% above the market average75.05% above the market average75.05% above the market average75.05% above the market average
67.44% above the sector average67.44% above the sector average67.44% above the sector average67.44% above the sector average67.44% above the sector average
Income
19.64% above the market average19.64% above the market average19.64% above the market average19.64% above the market average19.64% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
41.70% above the market average41.70% above the market average41.70% above the market average41.70% above the market average41.70% above the market average
57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 13
Sell 2
Strong Sell 0
Total 21
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 12-Nov-26 13-Aug-26
Paid 07-Jan-27 08-Oct-26
Amount 17.00p 17.00p

Trades for 20-Nov-2026

Time Volume / Share Price
15:00 46 @ 1,851.50p
15:00 442 @ 1,851.50p
15:00 185 @ 1,851.00p
15:00 41 @ 1,851.50p
15:00 307 @ 1,851.25p

GSK Key Personnel

CEO Luke Miels

Top of Page